Skip to content
OpenCapital
Get started

CareDx CDNA Reportable Segment — Total Revenue

Similar metrics at other companies

Travere Therapeutics, Inc. logo
TVTXReportable Segment — Total Revenue
$127.2M+55.6%
ARD
ARDTReportable Segment — Total Revenue
$1.6B+7.0%
GRAIL, Inc. logo
GRALReportable Segment — Total Revenue
$40.79M+28.1%
ADT logo
ADTReportable Segment — Total Revenue
$1.28B+0.9%
Novavax logo
NVAXReportable Segment — Total Revenue
$139.51M-79.1%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Total Revenue
$10.73M+2,873%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's reportable segment — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's reportable segment — total revenue?
CareDx (CDNA) reported reportable segment — total revenue of $117.7M in Q1 2026.
How has CareDx's reportable segment — total revenue changed year-over-year?
CareDx's reportable segment — total revenue increased by 39.0% year-over-year, from $84.69M to $117.7M.
What is the long-term trend for CareDx's reportable segment — total revenue?
Over 3 years (2022 to 2025), CareDx's reportable segment — total revenue has grown at a 5.7% compound annual growth rate (CAGR), from $321.79M to $379.81M.
What does reportable segment — total revenue mean?
Represents the total gross income generated from the sale of testing services, products, and digital solutions within the primary business segment. This metric serves as a key indicator of market demand and the company's ability to scale its precision medicine offerings for transplant patients.